Insurances & Business

Pfizer May Make Counter Bid For Ranbaxy: Report

Investment | Sources: bnet.com

Similar/Related/News:

• India’s Ranbaxy Falls Nearly 7 Percent After Lipitor Deal
NEW DELHI (Reuters) - Shares in Indian drugmaker Ranbaxy Laboratories Ltd <RANB.BO> fell nearly 7 percent on Thursday morning, after a paten...
• Ranbaxy May Use M&A to Grow in Japan Generics Market
TOKYO (Reuters) - India's Ranbaxy Laboratories Ltd <RANB.BO> sees tremendous opportunities for growth in Japan's generics drug market and me...
• Pfizer Names New General Counsel
NEW YORK (Reuters) - Pfizer Inc <PFE.N> on Wednesday named Amy Schulman, who has led litigation efforts for the drugmaker involving its pain...
• Pfizer Invests $300 Mln in Irish Biotech Facility
LONDON (Reuters) - Pfizer Inc <PFE.N>, the world's biggest drugmaker, is to invest 190 million euros ($297 million) establishing a new biote...
• Daiichi to Pay Up to $4.6 Billion For Control of Ranbaxy
TOKYO/NEW DELHI (Reuters) - Japanese drug maker Daiichi Sankyo Co Ltd <4568.T> moved to take majority control of India's biggest drug maker ...
• Pfizer Warns of Lung Cancer With Inhaled Insulin
NEW YORK (Reuters) - Pfizer Inc <PFE.N> and Nektar Therapeutics <NKTR.O> said on Wednesday clinical trials of the inhaled insulin Exub...
• Treasury Officials to Meet Wall Street Execs: Report
NEW YORK (Reuters) - Treasury Department officials plan private meetings with Wall Street executives and bankers, in an apparent attempt to counte...
• Movers roundup: Avant, Cypress Semiconductor (AP)
Shares of Avant Immunotherapeutics Inc. are climbing after the company licensed a cancer vaccine candidate to drug developer Pfizer....